Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00963274Phase 1Completed
Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
LeukemiaLymphoma
PrincipalinvestigatorStart date: 2010-04-26
NCT00865969Phase 2Completed
Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Peripheral T-cell Lymphoma
PrincipalinvestigatorStart date: 2008-12-15
NCT01075425Phase 1Completed
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous Leukemia+1 more
Principalinvestigator

Research Network

Collaboration Network

47 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven Grant

Virginia Commonwealth University

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score44%

Thomas C. Shea, MD

UNC Lineberger Comprehensive Cancer Center

Moderately Similar
9 trials

Shared therapeutic areas:

LymphomaLeukemiaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score34%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score26%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score26%

Steven Grant, MD

Virginia Commonwealth University

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score24%

Amy Kimball, MD, PhD

University of Maryland Greenebaum Cancer Center

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score24%

Sho Ma, MD, PhD

Northwestern University & Robert H Lurie Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score24%

Nishitha Reddy, MBBS

Vanderbilt-Ingram Cancer Center, Vanderbilt University

Related
1 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)Virginia Commonwealth University
Collaborated on 1 trial
Similarity Score24%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score17%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00963274Phase 1PrincipalInvestigator

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

LeukemiaLymphoma
Completed
NCT00865969Phase 2PrincipalInvestigator

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Peripheral T-cell Lymphoma
Completed
NCT01075425Phase 1PrincipalInvestigator

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Myelogenous Leukemia+1 more
Completed

All 3 trials loaded